pediatric dermatology

Rituximab Therapeutic Cheat Sheet
RituximabRituximab was the first monoclonal antibody approved for cancer treatment and now in dermatology, this medication has been life-altering for patients with the severe, autoimmune blistering disease, pemphigus vulgaris. We continue our series, Therapeutic Cheat Sheet, with a closer look at rituximab, which is FDA-approved for the treatment of pemphigus vulgaris, and is also used off label for other …
Rituximab
Pediatric Hair Loss: Nuances in Clinical Presentation and Therapeutics
pediatric hair lossNext Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Candrice Heath, assistant professor of dermatology at the Lewis Katz School of Medicine at Temple University. Every dermatology clinician should know some very specific things about hair loss, according to Dr. Heath, including that children can present with adult hair conditions. Watch as Dr. Heath outlines three condit …
pediatric hair loss
Pediatric Lesions – Wright-Giemsa Stain – Friday Pop Quiz 4/7/2023
Which of the following cell types is most likely to be found on a Wright-Giemsa stain of fluid from the lesions shown on this 2-day-old child? A. Basophils B. Eosinophils C. Histiocytes D. Mast cells E. Neutrophils To find out the correct answer and read the explanation, click here.    Brought to you by our brand partner  …
Pediatric Derm Emergencies & How to Treat Them
pediatric dermatologyNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Kalyani Marathe, director of the dermatology division at Cincinnati Children’s Hospital. Dr. Marathe shares serious pediatric skin issues including infections, drug reactions and congenital conditions. Watch and learn how to recognize and treat these serious issues, and how to know whe …
pediatric dermatology
Pediatric Rash – Friday Pop Quiz 12/30/2022
A 2 day-old infant is being seen in the hospital for the following rash. Which of the following is not true about the infant’s disease? A. Skin lesions typically resolve without scarring B. There is a strong association with anti-SSA/Ro antibodies C. There are also reports of the presence of U1RNP antibodies D. Lesions have a predilection for the face E. Heart block often deve …